Bayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follows over $7 billion in investments by Bayer in US pharmaceutical research and development. The facility aims to focus on critical areas including cancer, heart, and kidney care. It is expected to create around 600 permanent jobs and 1,500 construction jobs during its development.